Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative - A prospective study

被引:98
作者
Cerfolio, Robert James
Bryant, Ayesha S.
Eloubeidi, Alobamad A.
机构
[1] Univ Alabama Birmingham, Div Cardiothorac Surg, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Sch Publ Hlth, Thorac Surg Sect, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Dept Med, Div Gastroenterol & Hepatol, Birmingham, AL 35294 USA
关键词
endoscopic ultrasound; mediastinoscopy; non-small cell lung cancer; N2; negative;
D O I
10.1378/chest.130.6.1791
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Despite normal mediastinal (N2) lymph nodes shown on positron emission tomography (PET) and CT, some physicians routinely perform mediastinoscopy and/or endoscopic ultrasound fine-needle aspiration (EUS-FNA) in patients with non-small cell lung cancer (NSCLC). Methods: A prospective trial on patients with NSCLC who were clinically staged N2 negative by both integrated PET/CT and CT scan. All underwent mediastinoscopy and EUS-FNA and if N2 negative underwent thoracotomy with thoracic lymphadenectomy. Results: There were 153 patients (107 men). Of these, 136 patients were clinically staged NO and 17 patients were clinically staged N1. Of the 136 patients who were staged as NO, 5 patients (3.7%) had positive EUS-FNA results (three in the subcarinal node), and 4 patients (2.9%) had positive rnediastinoscopy results (all in the #4R node; one was N3). Six of the remaining 127 patients (4.7%) had N2 disease after resection. Seventeen patients were clinically staged as N1 by integrated PET/CT. Four patients (23.5%) had positive EUS-FNA results (two in the subcarinal node), 3 patients (17.6%) had positive mediastinoseopy results (all in #4R node; two were N2 and one was N3), and none of the remaining 10 patients had N2 disease after resection. Patients with unsuspected N2 disease were twice as likely (relative risk, 2.1; 95% confidence interval, 1.24 to 2.51; p = 0.02) to have a maximum standardized uptake value (maxSUV) > 10 and poorly, differentiated cancer (relative risk, 2.1; 95% confidence interval, 1.14 to 2.38; p = 0.03). Conclusion We do not recommend routine mediastinoscopy or EUS-FNA in patients who are clinically staged as NO after both integrated PET/CT and CT. However, these procedures should both be considered in patients clinically staged as NI after PET/CT, and/or in those with adenocarcinoma, upper-lobe tumors, or tumors with a maxSUV >= 10.
引用
收藏
页码:1791 / 1795
页数:5
相关论文
共 16 条
[1]   The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival [J].
Cerfolio, RJ ;
Bryant, AS ;
Ohja, B ;
Bartolucci, AA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (01) :151-159
[2]   Improving the inaccuracies of clinical staging of patients with NSCLC: A prospective trial [J].
Cerfolio, RJ ;
Bryant, AS ;
Ojha, B ;
Eloubeidi, M .
ANNALS OF THORACIC SURGERY, 2005, 80 (04) :1207-1214
[3]   Distribution and likelihood of lymph node metastasis based on the lobar location of nonsmall-cell lung cancer [J].
Cerfolio, Robert J. ;
Bryant, Ayesha S. .
ANNALS OF THORACIC SURGERY, 2006, 81 (06) :1969-1973
[4]   Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease) [J].
DeLeyn, P ;
Schoonooghe, P ;
Deneffe, G ;
VanRaemdonck, D ;
Coosemans, W ;
Vansteenkiste, J ;
Lerut, T .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1996, 10 (08) :649-654
[5]   Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans [J].
Eloubeidi, MA ;
Cerfolio, RJ ;
Chen, VK ;
Desmond, R ;
Syed, S ;
Ojha, B .
ANNALS OF THORACIC SURGERY, 2005, 79 (01) :263-268
[6]  
HADDAD FJ, 2006, IN PRESS J CARDIOTHO
[7]   Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location [J].
Kotoulas, CS ;
Foroulis, CN ;
Kostikas, K ;
Konstantinou, M ;
Kalkandi, P ;
Dimadi, M ;
Bouros, D ;
Lioulias, A .
LUNG CANCER, 2004, 44 (02) :183-191
[8]   Revisions in the International System for Staging Lung Cancer [J].
Mountain, CF .
CHEST, 1997, 111 (06) :1710-1717
[9]  
Nabi Hani A, 2002, J Nucl Med Technol, V30, P3
[10]   Lymph node sampling in lung cancer: how should it be done? [J].
Naruke, T ;
Tsuchiya, R ;
Kondo, H ;
Nakayama, H ;
Asamura, H .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1999, 16 :S17-S24